title: Intravitreal bevacizumab for iris metastasis of small-cell lung carcinoma with neovascular glaucoma.
authors.forename: Chikae
authors.initials: C
authors.lastname: Nakashima
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Keino
authors.forename: Takayo
authors.initials: T
authors.lastname: Watanabe
authors.forename: Wakako
authors.initials: W
authors.lastname: Taki
authors.forename: Annabelle A
authors.initials: AA
authors.lastname: Okada
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000959:Antihypertensive Agents / Q000008:administration & dosage; D000068258:Bevacizumab; D018288:Carcinoma, Small Cell / Q000188:drug therapy* / Q000556:secondary; D015355:Glaucoma, Neovascular / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D058449:Intravitreal Injections; D015811:Iris Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000959:Antihypertensive Agents; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab